C, M., R, C., M, G., & JS, P. (2025). Intraepithelial corneal deposits associated with Mirvetuximab soravtansine use for platinum-resistant ovarian cancer. American journal of ophthalmology case reports, 38, 102271. https://doi.org/10.1016/j.ajoc.2025.102271
Chicago Style (17th ed.) CitationC, McRae, Cowan R, Green M, and Parker JS. "Intraepithelial Corneal Deposits Associated with Mirvetuximab Soravtansine Use for Platinum-resistant Ovarian Cancer." American Journal of Ophthalmology Case Reports 38 (2025): 102271. https://doi.org/10.1016/j.ajoc.2025.102271.
MLA (9th ed.) CitationC, McRae, et al. "Intraepithelial Corneal Deposits Associated with Mirvetuximab Soravtansine Use for Platinum-resistant Ovarian Cancer." American Journal of Ophthalmology Case Reports, vol. 38, 2025, p. 102271, https://doi.org/10.1016/j.ajoc.2025.102271.